Ioannis Mantzaris
@YannisMantz
MD, MS, Associate Professor, @Montefiore/Einstein, acute leukemias, clinical research
Crispr modified CD70 allo CARs against T cell malignancies. Trial co-led by our outstanding Alex Sica in @TheLancetOncol @MontefioreNYC @EinsteinMed thelancet.com/journals/lanon…
🔥 Excited for our Phase 1 study Ven + 7+3 for Newly Diagnosed AML demonstrating 85% CR (86% MRD-neg) @BloodJournal @ MontefioreNYC @EinsteinMed @MontefioreNYC Eric J. Feldman @MendelGoldfing2 @mkonople @Amitvermamds @aditishasMD @Gritsman_lab #leusm doi.org/10.1182/blood.…
🔥 Our clinical trial of metronomic low-dose decitabine-ven in frontline MDS/ AML shows low tox, high efficacy & high response rate in TP53 mutant pts!! pubmed.ncbi.nlm.nih.gov/39316768/ @Amitvermamds @aditishasMD @YannisMantz @mkonople @Saunthararajah @MontefioreNYC @EinsteinMed #leusm